Metethoheptazine

Metethoheptazine^[1] (WY-535) is an opioid analgesic from the phenazepine family. It was invented in the 1960s.^[2]

Metethoheptazine

Clinical data
Other names	WY-535
ATC code	none
Identifiers
IUPAC name ethyl 1,3-dimethyl-4-phenylazepane-4-carboxylate
CAS Number	509-84-2 N
PubChem CID	176888
ChemSpider	154060 Y
UNII	S36J5ZY2TH
CompTox Dashboard (EPA)	DTXSID30862077
Chemical and physical data
Formula	C17H25NO2
Molar mass	275.392 g·mol−1
3D model (JSmol)	Interactive image
SMILES O=C(OCC)C2(c1ccccc1)CCCN(C)CC2C
InChI InChI=1S/C17H25NO2/c1-4-20-16(19)17(15-9-6-5-7-10-15)11-8-12-18(3)13-14(17)2/h5-7,9-10,14H,4,8,11-13H2,1-3H3 Y Key:BOSULDNQDJLKKL-UHFFFAOYSA-N Y
NY (what is this?)  (verify)

Metethoheptazine produces similar effects to other opioids, including analgesia, sedation, dizziness and nausea.

Metethoheptazine is not listed as a controlled substance under the Controlled Substances Act 1970 in the United States.^[3] The Canadian Controlled Drugs and Substances Act specifically excludes phenazepine opioids from control.